Announcements Trials
Browse Landscape

Phase

Phase 2 41Phase 3 25Phase NA 14Phase 1 6Phase 2/3 3Phase EARLY_PHASE1 2Phase 1/2 2Phase 4 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2

Conditions

Stomach Neoplasms 2Peritoneal Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT05300945 2022-12-06

HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy

Tongji Hospital

Phase 2/3 Not yet recruiting
200 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01091636 2020-02-17

Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer

National Cancer Center, Korea

Phase 2/3 Completed
184 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT01683864 2018-01-30

HIPECStomach

University Hospital Tuebingen

Phase 2/3 Terminated
3 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡